By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ZS Pharma 

508 Wrangler Drive
Suite 100
Coppell  Texas  75019  U.S.A.
Phone: 650-458-4100 Fax: 650-458-0084



Company News
Analysts Say ZS Pharma (ZSPH) Continues To Gain On Drug Approval 9/26/2014 12:10:26 PM
ZS Pharma (ZSPH) Announces Positive Top-Line Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia 9/24/2014 7:14:18 AM
ZS Pharma (ZSPH) To Present At The 21st Annual Biocentury Newsmakers Conference 9/17/2014 3:19:28 PM
ZS Pharma (ZSPH) Presents New Data From ZS003 A Two Week Phase 3 Trial Demonstrating That ZS-9 Prevented Recurrence Of Hyperkalemia In Heart Failure Patients On RAASi 9/16/2014 10:25:48 AM
ZS Pharma (ZSPH) To Present Data From Phase 3 Trial Of ZS-9 In Late-Breaking Session At Heart Failure Society Of America 18th Annual Scientific Meeting 9/11/2014 7:10:38 AM
ZS Pharma (ZSPH) To Present Late-Breaking Abstract Data From Phase 3 Trial Of ZS-9 In State Of The Art And Featured Research Session Oral Presentation At European Society of Cardiology Congress 8/26/2014 7:19:02 AM
ZS Pharma (ZSPH) Announces Second Quarter 2014 Financial Results 8/15/2014 8:01:03 AM
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014 6:43:17 AM
ZS Pharma (ZSPH) Completes Patient Enrollment In ZS004, Its Second Phase 3 Study Of ZS-9 In Patients With Hyperkalemia 7/15/2014 5:58:09 AM
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014 6:25:26 AM